文献速递术前评估与围术期医学心胸血管麻醉

非心脏手术后血管加压药使用:一项国际观察性研究

Vasopressor use after noncardiac surgery: an international observational study.
PubMed 文献 · Br J Anaesth · 2025-08-11

队列A中770/19 768(3.9%)接受术后血管加压药持续输注,各医院使用率0%至18%,校正病例组合后变异仍存在。术后血管加压药输注与更高的院内死亡率(15.5%)、器官衰竭率和更长住院时间相关。

要点

  • 非心脏手术后血管加压药持续输注总体发生率为3.9%,但医院间差异大(0%–18%)。
  • 医院间使用差异不能由病例组合和手术特征解释。
  • 术后血管加压药输注与更高院内死亡率、器官衰竭率和更长住院时间相关。

核心结论

  • 非心脏手术后血管加压药输注的医院间实践差异大,且与更差结局相关,该差异不能由病例组合差异解释。

研究设计与样本

  • 队列A为连续1周内所有连续患者,队列B为额外最多30例连续在1年内接受术后血管加压药输注的患者。
  • 共纳入25 675例参与者;主要结局为队列A术后血管加压药输注(任何持续输注)的发生率。

主要发现

  • 队列A中770/19 768(3.9%)参与者接受术后血管加压药输注。
  • 各医院血管加压药使用率范围为0%至18%,中位比值比2.30(可信区间1.96–2.73)。
  • 校正病例组合和手术特征后,医院间变异未改变。
  • 两个队列中,术后血管加压药输注与更高的院内死亡率(15.5%)、更高的器官衰竭率和更长住院时间相关。

临床怎么用

  • 麻醉科智能体应关注非心脏手术后血管加压药输注的高医院间变异,提示需结合本院实践评估术后低血压管理策略。
  • 术后启用血管加压药输注前应充分评估患者风险,因其与更差结局相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypotension after major noncardiac surgery is associated with increased morbidity, mortality, and costs, and is often treated with postoperative vasopressor infusions. The frequency of administration in the postoperative period is unknown. METHODS: This international prospective cohort study was conducted between October 2020 and October 2023. At each hospital, adults undergoing noncardiac surgery were enrolled into two cohorts: all consecutive patients for 1 week (Cohort A) and an additional sample of up to 30 consecutive patients administered postoperative vasopressor infusions within 1 yr (Cohort B). The primary outcome (Cohort A) was the incidence of postoperative vasopressor infusions, defined as any continuous infusion of vasopressors. Secondary outcomes included in-hospital mortality, organ dysfunction, length of hospital stay, and complications associated with postoperative vasopressor infusions (both cohorts). RESULTS: In total, 25 675 participants were enrolled from 228 hospitals across 42 countries. In Cohort A, 770/19 768 (3.9%) participants received postoperative vasopressor infusions, with vasopressor use ranging between 0% and 18% across hospitals (median odds ratio: 2.30 [credible interval 1.96-2.73]). This variability did not alter after adjustment for case-mix and procedural characteristics. For both cohorts, postoperative vasopressor infusions were associated with higher (15.5%) in-hospital mortality, higher rates of organ failure, and longer hospital stay. CONCLUSIONS: Administration of postoperative vasopressors after noncardiac surgery varied across hospitals and was associated with worse outcomes. Variable practice across hospitals could not be explained by differences in case-mix. CLINICAL TRIAL REGISTRATION: https://clinicaltrials.gov/study/NCT03805230, ESAIC tracking ID: ESAIC_CTN_SQUEEZE.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Jammer I, Martin P, Wunsch H, et al. Vasopressor use after noncardiac surgery: an international observational study. Br J Anaesth. 2025. PMID: 40796492. doi:10.1016/j.bja.2025.07.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。